D.C.’s New Crime Lab Goes Under the Microscope
By Editorial,
Washington Post Editorial
| 03. 11. 2015
WHAT’S THE point of spending millions of dollars on a crime lab if people don’t trust its findings and won’t use it? That is one question D.C. officials should be asking in light of the unsettling revelation that the U.S. Attorney’s Office has stopped sending DNA evidence to the new Consolidated Forensic Laboratory because it claims there have been serious mistakes. Far more than money is at issue: Forensics plays a key role in determining the guilt or innocence of crime suspects. The concerns of federal prosecutors must be investigated and the integrity of the lab assured.
In January federal prosecutors stopped sending evidence for DNA testing to the crime lab, which is operated by the District’s Department of Forensic Sciences, opting instead to pay for tests at outside labs. The move, as The Post’s Keith L. Alexander reported, came after an outside expert, in a routine review of evidence for an upcoming case, found errors in the interpretation of test results; a subsequent review of 116 cases by two nationally known experts found what federal prosecutors characterized as...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...